Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Methods of treating hematological proliferative disorders by targeting EphA3 expressed on aberrant vasculature in bone marrow

US Patent 9109032 · Granted Aug 18, 2015

Estimated economic value: $208,000

Assignee

Inventors

View full patent text on Google Patents →